Subscribe
gavel-istock-509557490-brianajackson
brianajackson / iStockphoto.com
29 March 2018Americas

Federal Circuit orders stay of PTAB’s Restasis proceedings

The US Court of Appeals for the Federal Circuit has ordered the Patent and Trial Appeal Board (PTAB) to halt its review of patents covering a dry eye medication while the court considers arguments that tribal immunity protects the patents from board proceedings.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Allergan-tribe ruling raises questions over immunity at PTAB: lawyers
24 July 2018   The US Court of Appeals for the Federal Circuit’s ruling that tribal sovereign immunity doesn’t apply in inter partes review proceedings has sparked questions over state protections at the Patent Trial and Appeal Board.
Americas
Tribal immunity not applicable in IPR, says Fed Circuit
20 July 2018   Allergan and the Saint Regis Mohawk Tribe suffered a blow today as the US Court of Appeals for the Federal Circuit affirmed a decision rejecting use of tribal sovereign immunity in the inter partes review.
Americas
Allergan and tribe to appeal PTAB’s immunity decision
2 March 2018   The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Americas
Allergan-tribe ruling raises questions over immunity at PTAB: lawyers
24 July 2018   The US Court of Appeals for the Federal Circuit’s ruling that tribal sovereign immunity doesn’t apply in inter partes review proceedings has sparked questions over state protections at the Patent Trial and Appeal Board.
Americas
Tribal immunity not applicable in IPR, says Fed Circuit
20 July 2018   Allergan and the Saint Regis Mohawk Tribe suffered a blow today as the US Court of Appeals for the Federal Circuit affirmed a decision rejecting use of tribal sovereign immunity in the inter partes review.
Americas
Allergan and tribe to appeal PTAB’s immunity decision
2 March 2018   The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.

More on this story

Americas
Allergan-tribe ruling raises questions over immunity at PTAB: lawyers
24 July 2018   The US Court of Appeals for the Federal Circuit’s ruling that tribal sovereign immunity doesn’t apply in inter partes review proceedings has sparked questions over state protections at the Patent Trial and Appeal Board.
Americas
Tribal immunity not applicable in IPR, says Fed Circuit
20 July 2018   Allergan and the Saint Regis Mohawk Tribe suffered a blow today as the US Court of Appeals for the Federal Circuit affirmed a decision rejecting use of tribal sovereign immunity in the inter partes review.
Americas
Allergan and tribe to appeal PTAB’s immunity decision
2 March 2018   The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB